4//SEC Filing
Meyer Andrew Hollman 4
Accession 0001864159-25-000005
CIK 0001817713other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:00 PM ET
Size
8.8 KB
Accession
0001864159-25-000005
Insider Transaction Report
Form 4
Meyer Andrew Hollman
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-14$10.59/sh+3,333$35,296→ 88,307 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-14−3,333→ 118,101 totalExercise: $10.59Exp: 2031-05-13→ Common Stock (3,333 underlying) - Sale
Common Stock
2025-11-14$30.00/sh−3,333$99,990→ 84,974 total
Footnotes (3)
- [F1]Includes 1 share acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2024 and 2,834 shares acquired under the Plan on May 15, 2025.
- [F2]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.
- [F3]Immediately exercisable.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001864159
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:00 PM ET
- Size
- 8.8 KB